Possibilities of multimodal neuroprotection in patients with chronic cerebral ischemia on the background of arterial hypertension and atherosclerosis
This article is in “Library” – “Neurology” - "CCR: Chronic cerebrovascular disorder" section.
Author:
GRIBACHEVA I.A., POPOVA T.F., PETROVA E.V., ZVONKOVA A.V.
Novosibirsk State Medical University, Ministry of Health of Russia, Novosibirsk
Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases
This article is in “Library” – “Covid-19” section.
Author:
E.B. KUZNETSOVA, E.A. SALINA, N.S. KUZNETSOV
Razumovsky Saratov State Medical University, Saratov, Russia
Clinico-psychological profile and life quality of patients with post-COVID syndrome
This article is in “Library” – “Covid-19” section.
Author:
L.V. CHICHANOVSKAYA, T.A. SLYUSAR, YU.V. ABRAMENKO, T.M. NEKRASOVA, I.N. SLYUSAR
Tver State Medical University, Tver, Russia
International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® forte 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension
This article is in “Library” – “Neurology” - "CCR: Chronic cerebrovascular disorder" section.
Author:
ZAKHAROV V.V.1, OSTROUMOVA O.D.1,2, KOCHETKOV A.1,2, KLEPIKOVA M.V.2, FEDIN A.1,3
1I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
2Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia, Moscow
3N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow
Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis
This article is in “Library” – “Neurology” - "CCR: Chronic cerebrovascular disorder" section.
Author:
T.L. VIZILO1, E.G. AREFIEVA2
1Kemerovo State Medical University, Kemerovo, Russia;
2Barbarash Kuzbass Clinical Cardiological Dispensary , Kemerovo, Russia
Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke
This article is in “Library” – “Covid-19” section.
Author:
G.S. RAKHIMBAYEVA, SH.R. GAZIEVA, M.K. ATANIYAZOV, F.H. MURATOV, D.S. TOLIPOV, U.D. SHODIEV
Tashkent Medical Academy, Tashkent, Republic of Uzbekistan
Oxidative stress in the pathogenesis of stroke and its correction
This article is in “Library” – “Neurology” - "CCT" section.
Author:
M.YU. MARTYNOV1,2, M.V. ZHURAVLEVA3,4, N.S. VASYUKOVA5, E.V. KUZNETSOVA6, T.R. KAMENEVA7
1Pirogov Russian National Research Medical University, Moscow, Russia;
2Federal Center of Brain Research and Neurotechnologies, Moscow, Russia;
3Research Center for Examination of Medical Devices, Moscow, Russia;
4Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
5Skriabin and Kovalenko Institute of Experimental Veterinary Medicine, Moscow, Russia;
6Research Institute for Healthcare and Medical Management, Moscow, Russia;
7Konchalovsky City Clinical Hospital, Moscow, Russia
Cognitive disorders of vascular genesis in the practice of a therapist
This article is in “Library” – “Therapy” - section.
Author:
P.R. KAMCHATNOV1, R.A. CHEREMIN2, L.A. SKIPETROVA2, A.V. CHUGUNOV1
1N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow
2Center of Speech Pathology and Neurorehabilitation of the Moscow Healthcare Department
Results of clinical studies of the efficacy and safety of the use of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia
This article is in “Library” – “Neurology” – “CCR: Chronic Cerebrovascular Disorder” section.
Author:
M.V. ZHURAVLEVA1,2, P.R. KAMCHATNOV3, N.S. VASYUKOVA4, V.V. ARKHIPOV1, E.V. KUZNETSOVA5, T.R. KAMENEVA6, S.YU. SEREBROVA1,2
1Research Center for Examination of Medical Devices, Moscow, Russia;
2Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
3Pirogov Russian National Research Medical University, Moscow, Russia;
4Skriabin and Kovalenko Institute of Experimental Veterinary Medicine, Moscow, Russia;
5Research Institute for Healthcare and Medical Management, Moscow, Russia;
6Konchalovsky City Clinical Hospital, Moscow, Russia
Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)
This article is in “Library” – “Neurology” - "CCR: Chronic Cerebrovascular Disorder" section.
Author:
V.V. ZAKHAROV1, O.N. TKACHEVA2,3, E.A. MKHITARYAN2,3, A.I. FEDIN2
1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2Pirogov Russian National Research Medical University , Moscow, Russia;
3Russian Clinical and Research Center of Gerontology, Pirogov Russian National Research Medical University , Moscow, Russia